{"text_format":"3","workbook":"xls","n_sheets":3,"sheets":["Table 1","Table 2","Table 3"],"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Table 1","index":0,"n_rows":15,"n_cols":4,"rows_kept":15,"merged":[[6,0,8,0],[9,0,10,0]],"flags":["formulas_cached_only"]}
["Table 1. Patient characteristics"]
[]
[{"$nulls":3},"(N=89)"]
["Age (yrs)","Median (range)",63,"(13-84)"]
["Sex","Male",29,{"v":0.326,"d":"32.6%"}]
[null,"Female",60,{"v":0.674,"d":"67.4%"}]
["Histrogical analysis of primary tumor","PTC",80,{"v":0.899,"d":"89.9%"}]
[null,"PTC-folllicular variant",2,{"v":0.022,"d":"2.2%"}]
[null,"FTC",7,{"v":0.079,"d":"7.9%"}]
["Metastases at first RAI treatment","Yes",44,{"v":0.494,"d":"49.4%"}]
[null,"No",45,{"v":0.506,"d":"50.6%"}]
["The cumulative RAI dose (GBq)","Median (range)",8.51,"(1.11-42.55)"]
["The cumulative RAI time (times)","Median (range)",3,"(1-12)"]
["The median follow-up time from first RAI treatment (Mos)","Median (range)",62.6,"(0.1-175.3)"]
["RAI; Radioactive iodine, PTC; Papillary thyroid carcinoma, FTC; Follicular thyroid carcinoma."]

{"sheet":"Table 2","index":1,"n_rows":7,"n_cols":15,"rows_kept":7,"flags":["formulas_cached_only"]}
["Table 2. The survival times from diagnosis of BM"]
["Case","Age (yrs)/ Sex","Histology of primary tumor","Metastasis at first RAI","Metastasis at diagnosis of brain metastasis","Cumulative RAI dose (GBq)","Cumulative RAI number  (times)","Number of brain metastases","Maximum size of lesion (mm)","Hemorrhage","Interval from diagnosis of primary tumor to brain metastasis (yrs.)","Interval from first RAI treatment to brain metastasis (mos.)","Interval from diagnosis of brain metastasis to hemorrhage (mos.) ","Treatment","Outcome (months)"]
[1,"64/F","PTC","Lung","Lung",19.61,6,1,40,"No",21,52.1,"Not occurred","Resection, WBRT and RAI","Died in 13.1 months"]
[2,"61/F","PTC ","Lung","Lung, bone",27.01,8,2,23,"Yes",11.5,101.5,3.6,"No","Died in 3.6 months"]
[3,"81/F","PTC","Lung, bone","Lung, bone",8.51,3,1,12,"Yes",2.5,20.5,{"v":1,"d":"1.0"},"No","Died in 13.0 months"]
[4,"63/M","PTC","Lung","Lung, pleura",15.91,5,1,"N.A.","Yes ",6.7,73.1,"Simultaneous","Resection","Died in 2.5 months"]
["M Male, F Female, PTC Papillary thyroid cancer, N.A. not available, RAI Radioactive iodine, WBRT Whole brain radiotherapy"]

{"sheet":"Table 3","index":2,"n_rows":8,"n_cols":11,"rows_kept":8,"flags":["formulas_cached_only"]}
["Table 3. Summary of previous reports of patients with hemorrhagic brain metastasis from thyroid cancer"]
["Author (year)","Case","Age (yrs)/ Sex","Histology of primary tumor","Symptoms","The number of lesion","Maximum size of lesion (mm)","Interval from diagnosis of primary tumor to brain metastasis (yrs)","Interval from diagnosis of brain metastasis to hemorrhage ","Treatment","Outcome"]
["Tahmasebi FC et al. (2013)",1,"70/F","PTC (Oncocytic)","Headache and ataxia",1,34,{"v":17,"d":"17.0"},"Simultaneous","Resection  and RAI treatment","Died in 6 months"]
["Tahmasebi FC et al. (2013)",2,"69/M","PTC (Classic variant)","Headache",2,40,6.5,"Simultaneous","Resection  and RAI treatment","Alive at 6 months"]
["Isoda H et al. (1997)",3,"40/F","PTC","Cerebellar ataxia",2,30,0,"Revealed at surgical resection","Resection  and RAI treatment","Alive at 22 months"]
["Tanaka T et al. (2013)",4,"63/F","PTC","Headache and dizziness",1,30,5.8,"Simultaneous","Resection  and  SRS","Alive at 23 months"]
["Tsuda K et al. (2013)",5,"43/F","PTC","N.A.","Multiple","N.A.",0.8,"N A. (Died of hemorrhage)","Resection  and RAI treatment","Died in 11 months"]
["M Male, F Female, PTC Papillary thyroid cancer, N.A. not available, RAI Radioactive iodine, SRS Stereotactic radiosurgery"]